CNS Pharmaceuticals (CNSP.Q), the company that licenses the drug candidate Berubicin to WPD Pharmaceuticals, announced today that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation…
cancer treatment
Advaxis (ADXS.Q), a clinical-stage biotechnology company, and Biosight, a privately held pharmaceutical development company developing innovative therapeutics for hematological malignancies and disorders, announced today that the companies have entered…
Aravive (ARAV.Q), a clinical-stage oncology company developing innovative therapeutics to treat life-threatening diseases, announced positive initial results today from the Phase 1b portion of its Phase 1b/2 study of…
Aion Therapeutics’ (AION.C) joint testing with Apollon Formularies has revealed that their combined formulations are effective in killer HER-positive (HER2+) breast cancer cells. “Our recent medicinal mushroom formulation testing…
“Psilocybin offers a potential solution to manage moderate to severe cases of TBI,” stated RVV, “Psilocybin has the potential with its neuroreparative effect to improve loss of cognitive function…
The PCR test system demonstrated clinical accuracy in detecting SARS-CoV-2 RNA within 25 minutes, making it an ideal screening tool for international airports….
“PCR tests are used to directly detect the presence of an antigen, rather than the presence of the body’s immune response, or antibodies,” states Medical Device Network, “By detecting…
The PCR test system demonstrated clinical accuracy in detecting SARS-CoV-2 RNA within 25 minutes, making it an ideal screening tool for international airports….
Xphyto describes itself as “a bioscience accelerator” “targeting growth through commercialization of its product pipeline”….
Investor focus is currently bifurcated between a potential FDA bucillamine approval, and RVV’s ambitions and partnerships in the shroom space….